2ION
Crystal structure of the C-terminal MA3 domain of Pdcd4 (mouse); form2
2ION の概要
エントリーDOI | 10.2210/pdb2ion/pdb |
関連するPDBエントリー | 2IOL 2IOS |
分子名称 | Programmed Cell Death 4, Pdcd4, GLYCEROL (3 entities in total) |
機能のキーワード | alpha-helical, antitumor protein |
由来する生物種 | Mus musculus (house mouse) |
細胞内の位置 | Nucleus : Q61823 |
タンパク質・核酸の鎖数 | 1 |
化学式量合計 | 17655.21 |
構造登録者 | |
主引用文献 | Laronde-Leblanc, N.,Santhanam, A.N.,Baker, A.R.,Wlodawer, A.,Colburn, N.H. Structural basis for inhibition of translation by the tumor suppressor pdcd4. Mol.Cell.Biol., 27:147-156, 2007 Cited by PubMed Abstract: The tumor suppressor function of Programmed Cell Death 4 (Pdcd4) is achieved through interactions between Pdcd4 and components of the translation initiation complex, namely, the RNA helicase eIF4A and the scaffolding protein eIF4G. These interactions are mediated through two MA3 domains on the Pdcd4 molecule and result in inhibition of protein synthesis. We have solved the high-resolution crystal structure of the C-terminal MA3 (cMA3) domain of Pdcd4 in several crystal forms and demonstrated its similarity to the MA3 domain of eIF4G. As predicted by the structure, the cMA3 domain competes with eIF4Gc for binding to eIF4A and surprisingly is sufficient to inhibit translation initiation. Mutations that abolish eIF4A binding negate both functions of the cMA3. Interestingly mutations in the Akt phosphorylation site influenced neither cMA3 binding to eIF4A nor its ability to inhibit translation initiation. Finally, our structural analysis reveals MA3 domains to be a novel subfamily of VHS domains. PubMed: 17060447DOI: 10.1128/MCB.00867-06 主引用文献が同じPDBエントリー |
実験手法 | X-RAY DIFFRACTION (1.57 Å) |
構造検証レポート
検証レポート(詳細版)をダウンロード